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Predicting Future Sources
of Mass Toxic Tort Litigation*
Jeffery A. Foran, Bernard D. Goldstein,
John A. Moore & Paul Slovic**
Introduction
U.S. toxic tort litigation has received a great deal of recent
attention, particularly regarding issues of admissibility of scientific
evidence concerning the strength of causal relationships between
exposure and injury.' Foster et al.2  have offered several
recommendations, and other efforts have been initiated to assist courts
in improving the resolution of scientific issues.3
* Funding was provided to the ILSI Risk Science Institute by The State Justice
Institute (SJI) through the Center for Health Policy Research (CHPR), George
Washington University. This paper represents the thoughts of the working group and
not necessarily the positions or opinions of the SJI or the CHPR. We are grateful for
the comments of Richard Adamson, Henry Anderson, Robert Brent, Fred Degnan,
Dimitrios Trichopoulos and Phil Watanabe on an earlier draft.
** Dr. Foran is Executive Director of the ILSI Risk Science Institute. He received his
B.S. (Biology) from the University of Michigan, his M.S. (Biology) from Central
Michigan University and his Ph.D. (Environmental Engineering Sciences) from the
University of Florida.
Dr. Goldstein is Director, Environmental and Occupational Health Sciences
Institute and Chair, Environmental and Community Medicine at the University of
Medicine and Dentistry of New Jesrsey. He received his B.S from the University of
Wisconsin-Madison and his M.D. from New York University.
Dr. Moore is President and CEO of the Institute for Evaluating Health Risks. He
received his B.S., M.S. and D.V.M. from Michigan State University.
Dr. Slovic is President of Decision Research and Professor of Psychology,
University of Oregon. He received his B.A. from Stanford and his MA. and Ph.D.
from the University of Michigan.
1 Eliot Marshall, Supreme Court to Weigh Science, 259 Science 588 (1993) and
Ronald D. Hood, Some Considerations for the Expert Witness in Cases Involving
Birth Defects, 8 Reprod. Toxicol. 269 (1994).
2 Kenneth R. Foster, David E. Bernstein & Peter W. Huber, Science and the
Toxic Tort, 216 Science 1509 (1993).
3 Carnegie Commission on Science, Technology, and Government, Science and
Technology in Judicial Decision Making: Creating Opportunities and Meeting
Challenges (1993) and American Association for the Advancement of
Science-American Bar Association, National Conference of Lawyers and Scientists
Task Force on Science and Technology in the Courts, Enhancing the Availability of
Reliable and Impartial Scientific and Technical Expertise to the Federal Courts (A
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Multiple litigation on the same form of exposure with many
plaintiffs, and often more than one defendant, taxes both state and
federal court systems beyond the point where cases can be addressed in
a reasonable and timely fashion. For example, courts are burdened by
bendectin and silicone breast implant litigation and face over 100,000
remaining asbestos cases. That onslaught of cases is complicated by
their being penetrated by complex scientific issues. Thus, early
identification of potential sources of such litigation will help courts to
predict, prepare for, respond to and manage demands imposed by the
next round of equivalent litigation.
Courts can do so in several ways including:
" Consolidating cases and creating coordinated discovery;
" Creating central repositories for information;
* Developing a knowledge base of related scientific issues;
* Creating and using alternatives such as court-appointed
experts or independent neutral evaluators; and
" Possibly referring issues to entitities equipped to handle
legal issues with complex scientific content.
The judicial system is not prepared, however, to determine from
individual cases which may be precursors of mass tort litigation; thus
the ability to implement appropriate management steps is limited.
Therefore, the ILSI Risk Science Institute convened an expert working
group4 to identify potential sources of future mass litigation and their
Report to the Carnegie Commission on Science, Technology, and Government)
(1991). See also, Which Scientist Do You Believe? Process Alternatives is
Technological Controversies, 6(2) Risk (1995) (a symposium).
4 Besides the authors, the group was remarkably diverse: Richard H. Adamson,
Vice President, Scientific and Technical Affairs, National Soft Drink Association,
holds a Ph.D. in pharmacology. Henry A. Anderson, Environmental and
Occupational Disease Epidemiologist, Wisconsin Department of Health and Social
Services, holds an M.D. Rosalyn B. Bell recently retired from the Court of Special
Appeals of Maryland, at large. Robert L. Brent, Chair, Pediatrics, Jefferson Medical
College, is also Director ofthe Clinical and Experimental Teratology Laboratories at
the Alfred I. du Pont Institute Children's Hospital. Christine D. Copple, Industrial
Liaison, University of Maryland Biotechnology Institute, holds a Ph.D. in molecular
biology. J. Clarence Davies, Director of the Center for Risk Management, Resources
for the Future, holds a Ph.D. in American Government. Frederick H. Degnan is a
partner in the King & Spalding law firm. James L. Emerson, Director, Scientific &
Regulatory Affairs, The Coca-Cola Company, holds a D.V.M. and a Ph.D. Ronald J.
Kendall, Head, Department of Environmental Toxicology and Director of the
Institute of Wildlife and Environmental Toxicology, Clemson University, holds a
Ph.D. in fisheries and wildlife sciences/toxicology. George W. Lucier, Chief,
Laboratory of Biochemical Risk Analysis, Nat'l Inst. Environmental Health Sciences,
holds a Ph.D. Margaret Mellon directs the program on Agriculture and
Biotechnology at the Union of Concerned Scientists and holds a Ph.D. and J.D.
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characteristics - with primary emphasis on toxic torts over the next
five to ten years. The material presented here and summarized in Table
1 represents the consensus conclusions of that working group.
Table 1
Potential Sources of Mass Toxic Tort Litigation and Their Characteristics
Potential Sources
New technologies that are developed
rapidly with influence from economic
and political incentives
Technology that improves the ability
to detect diminishingly small quantities
of potentially harmful substances
Technology that improves the ability
to "fingerprint"
Compounds, products, or processes
limited by safety/hazard testing
Compounds, products, or processes
that cause environmental damage
Characteristics
Signature disease (e.g. mesothelioma)
Common, familiar, adverse effect with
long-term societal stigma such as:
cancer, birth/developmental defects,
reproductive impairment, mental im-
pairment, genetic disease
Plausible but not necessarily certain link
between exposure and adverse effect
High degree of dread
Widespread, involuntary exposure
Victims who elicit sympathy (e.g. young
children, pregnant women)
Compound/product/activity identified
on a list of hazards
Identifiable, opprobrious defendant with
"deep pocket"
Widespread awareness of issue
Potential Sources of Mass Tort Litigation
Potential sources of mass toxic tort litigation are highly diverse.
Particularly susceptible to mass tort litigation are new technologies,
reinforced by strong economic, political, environmental, legal or other
Dorothy E. Patton, Executive Director, U.S. EPA's Science Policy Council, holds a
Ph.D. in developmental biology. Noel R. Rose is a Professor in the Departments of
Immunology and Infectious Diseases, Medicine, and Environmental Health Sciences
at the Johns Hopkins University. Sandra S. Thurston, manager at the State Justice
Institute, holds a J.D. Dimitrios Trichopoulos is Chair, Department of Epidemiology,
Harvard School of Public Health and Professor of Hygiene and Epidemiology,
University of Athens Medical School. Philip G. Watanabe recently retired from the
Dow Chemical Company as a senior advisor for human health and environmental
issues and holds a Ph.D. in toxicology. Franklin M. Zweig, President, Einstein
Institute for Science, Health, & The Courts, holds a Ph.D. and J.D.
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incentives to move aggressively toward implementation. The potential
for litigation is reinforced where adequate knowledge has not been
developed to determine which adverse effects may occur. For example,
genetic and other new, untested or poorly tested, and rapidly
implemented technologies have the potential for considerable
economic, environmental and health benefits. Yet, they may also cause
health or environmental harm and be the basis for mass tort litigation.
Genetic technologies may also contribute indirectly to the potential for
such litigation by strengthening cause/effect linkages through
identification of sensitive populations, informing particularly sensitive
individuals in exposed populations, encouraging discrimination against
sensitive individuals through exclusion from jobs, or disseminating
information on individuals' genetic composition.
New or improved capability to detect diminishingly small
quantities of toxic substances may also contribute to the potential for
mass litigation. As detection technologies improve, awareness of
exposure will increase and may contribute directly to that potential,
particularly associated with non-threshold acting substances. Individuals
who become aware of exposure to these substances may conclude, "I
am exposed, therefore I am harmed." Mass litigation may follow
despite lack of any demonstrable causal relationship between exposure
and adverse effect. Improved capability to "fingerprint" may contribute
further to the potential for mass tort litigation where a chemical or
contaminated food product to which exposure has occurred can be tied
directly to an entity that manufactures the material. The same
fingerprinting technology may, however, also allow a chemical, food
product, or other material to be identified specifically enough to
dismiss an entity as a potential source; thus, eliminating the likelihood
that the entity will become involved in mass tort litigation.
Products subject to hazard and safety testing are also potential
sources of mass tort litigation. Historical and existing limitations of
hazard or safety testing for chemicals, compounds, or products, or the
time necessary to acquire scientific information to support or weaken a
putative cause/effect relationship may be important contributors to the
potential for mass tort litigation. Adverse effects that are missed in
hazard or safety testing may result ultimately in mass tort litigation.
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Toxic effects may be missed due to differences in species susceptibility
or due to the restricted size of screening populations compared with
exposed human populations. Remote effects, those that occur many
years after exposure or that are of a kind not predicted from the known
or expected toxicological or pharmacological effects of the compound
(based on structure or on what is known of the chemistry and
metabolism of the compound), may also increase the likelihood that an
adverse effect will be missed in hazard or safety testing.
Substances such as pesticides that were once managed primarily for
human health effects, may now be evaluated and prioritized quite
differently and may become sources of mass tort litigation stimulated
by ecological damage, reflecting the important influence of social values
in identification of future sources of litigation. An emergence of public
concern for environmental effects, reflected by existing environmental
protection legislation such as the Migratory Bird Treaty Act5 or the
Endangered Species Act6 (that provide vehicles for determination of
harm to the environment), may also contribute to the potential for mass
tort litigation. Technologies that are rapidly implemented for
environmental protection purposes without a complete understanding
of their effects on humans or other components of the environment,
may also be prime candidates for mass tort litigation.
Characteristics of Potential Sources
Each potential source of toxic tort litigation must either cause some
injury or stimulate the perception of injury. Products, compounds or
activities that cause widespread, concrete, familiar and recognizable
primary medical events are the most likely sources. However, relatively
rare events, that allow invocation of exclusionary probabilistic
arguments, may also become sources. Primary events include signature
diseases (e.g. mesothelioma related to asbestos exposure) with a high
degree of scientific certainty, effects with persistent or long-term
societal stigma such as cancer or mental retardation, or reproductive
5 Codified at 16 U.S.C. § 703 et seq.; c. 128 § 2, 40 Stat. 755 (1918); c. 634 § 3,
49 Stat. 1556 (1036); Pub.L. 93-300 § 1, 88 Stat. 190 (1974); Pub.L. 101-233 § 15,
103 Stat. 1977 (1989).
6 Codified at 16 U.S.C. § 1531 et seq.; Pub.L. 93-205 § 2, 87 Stat. 884 (1973);
Pub.L. 96-159 § 1, 93 Stat. 1225 (1979); Pub.L. 97-304 § 9(a), 96 Stat. 1426. (1982);
Pub.L. 100-478, Tide II § 1013(a), 102 Stat. 2315 (1988).
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problems or birth defects that transcend generations. Less obvious
effects may also result in mass tort suits, particularly where effects are
enhanced or influenced by strong social values. For example, a decline
in property value may be caused by the transport of hazardous waste
along a roadway even though it causes no direct adverse health or
environmental effects. In this case, litigation may stem from economic
damage caused by the perceived risks associated with the activity.
Actual demonstration of injury is not necessary for any source as
long as the perception of injury exists. Conclusive establishment of a
specific cause for the injury (firm establishment of a cause/effect
relationship) is also not required for a compound, product, or activity
to become a source of mass tort litigation. However, some form of
plausible causality, although not necessarily scientifically proven link
between injury and exposure, will increase the likelihood of mass tort
litigation. Establishment of the injury/exposure link may be
strengthened where allegations by scientists support the linkage, or
where the frequency of occurrence is, or is perceived to be, increasing.
To become a source of mass tort litigation, a compound, product,
or activity must not only cause injury or the perception of injury, but
must be identifiable and detectable itself as well as identified with a
source. Once identified, the likelihood of a compound, product, or
activity becoming a source of mass tort litigation may be increased as
the degree of dread is increased. The degree of dread may be enhanced
by a lack of knowledge of the compound, product, or activity, the
degree to which it is deemed to pose involuntary risk or injury, and by
effects that are trans-generational or possess long-term societal stigma.
Dread may be enhanced further by the appearance of a compound,
product, or activity on a list that is widely circulated (e.g. list of known
or suspected carcinogens, list of known or suspected
reproductive/developmental toxicants, etc.).
Compounds, products or activities that produce or are likely to
result in widespread (constant or repetitive) exposure are candidates for
mass tort litigation; e.g., products added to components of the food
supply or gasoline have such potential. Their potential is increased when
parts of the exposed population evoke particular sympathy, e.g.,
children, pregnant women, the elderly or endangered species.
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Finally, mass litigation must have at least one identifiable defendant
with resources that appear adequate to support a large award for
damages. The potential for litigation is enhanced where that defendant
is recognizable, has been previously involved in litigation and is
intentionally or unintentionally opprobrious. Widespread awareness of
the problem, enhanced by an individual who publicizes it or legislative
or scientific interest that raises public consciousness regarding both the
effect and potential defendants also increase litigation potential.
Discussion
The ability to predict future sources of mass toxic tort litigation will
provide the courts with a powerful tool to improve the effective
management of complex cases. Although the accurate prediction of
future sources of toxic tort litigation will be difficult, compounds,
products, or activities that possess some or all of the characteristics
described above are likely to have a greater probability of becoming
sources of mass tort litigation.
To enhance courts' ability to predict future sources of toxic tort
litigation, we recommend:
• Developing a database to document past instances and
characteristics of sources of mass litigation and
* Establishing a monitoring or early warning system to
alert courts of an impending landslide of cases.
The early warning system should systematically monitor buildups or
trends of litigation associated with similar exposures. Insights gained
from the database and this exercise should then be used to determine
the potential of "suspicious" cases to develope into mass tort litigation.
Lessons to develop such a system may be drawn from, or find
useful analogs in, early warning and monitoring systems as diverse as
those for natural disaster prevention or the stock market. Such a system
could be useful for forecasting far in advance of a deluge of tort
litigation. However, it must be developed and applied cautiously so
that it does not encourage litigation by unduly stigmatizing an entity
that possesses a set of facilitating characteristics.
The effective use of science in the courts, particularly for
determinations of admissibility and causation is limited for two
important reasons. First, judges and lawyers are typically not trained as
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scientists and should not be expected to assimilate a great deal of
complex scientific information. Second, the time lag between the
appearance of an alleged injury and exposure to a toxic substance, and
the conduct of research that addresses the cause/effect relationship
reduces the utility of science in the courts. Many sources of mass tort
litigation develop initially as case histories or medical anecdotes. With
the accumulation of anecdotes, awareness of a possible problem
encourages litigation. Further scientific investigation is usually necessary
to better define and understand the problem and to delineate the
parameters of any alleged cause/effect relationship. Unfortunately,
scientific research that definitively resolves the issue may take several
years, during which time the first cases may have already been decided,
encouraging mass litigation. The judicial process is now incapable of
allowing science to catch up with anecdotal evidence that contributes to
tort litigation. In fact, litigation may interfere with gathering or analysis
of scientific information where access to data on affected individuals
and ecosystems is restricted to scientists directly involved in litigation.
Outside scientists without an opportunity to analyze information on,
e.g., cause/effect relationships cannot provide the insight that might
come from additional research.
Givien problems with use cf science by courts, the prediction of
potential sources of mass tort litigation should provide important
management assistance. Also, where a company is aware of
characteristics associated with potential sources of mass tort litigation in
its products or processes, it may be able to reduce or eliminate those
characteristics. That would provide benefits to the company as well as
social relief through a reduction in both real or perceived harm and the
amount of litigation to be handled by courts.
